160 related articles for article (PubMed ID: 38019244)
1. An Analytical Study to Determine Dose-Volume Threshold for Radiation Induced Hypothyroidism.
Pravesh K; Sethi P; Kamalanathan SK; Manavalan M
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3859-3866. PubMed ID: 38019244
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced hypothyroidism after treatment of head and neck cancer.
Feen Rønjom M
Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931197
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy.
Pinnix CC; Cella L; Andraos TY; Ayoub Z; Milgrom SA; Gunther J; Thosani S; Wogan C; Conson M; D'Avino V; Oki Y; Fanale M; Lee HJ; Neelapu S; Fayad L; Hagemeister F; Rodriguez MA; Nastoupil LJ; Nieto Y; Qiao W; Pacelli R; Dabaja B
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):530-540. PubMed ID: 29681481
[TBL] [Abstract][Full Text] [Related]
4. Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review.
Chow JCH; Cheung KM; Cheung GTC; Tam AHP; Lui JCF; Lee FKH; Au KH; Ng WT; Lee AWM; Yiu HHY
Clin Transl Radiat Oncol; 2022 Mar; 33():83-92. PubMed ID: 35128087
[TBL] [Abstract][Full Text] [Related]
5. Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors.
Wang C; Hou Y; Wang L; Yang Y; Li X
BMC Cancer; 2024 Jan; 24(1):5. PubMed ID: 38166748
[TBL] [Abstract][Full Text] [Related]
6. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
Diaz R; Jaboin JJ; Morales-Paliza M; Koehler E; Phillips JG; Stinson S; Gilbert J; Chung CH; Murphy BA; Yarbrough WG; Murphy PB; Shyr Y; Cmelak AJ
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):468-76. PubMed ID: 19577867
[TBL] [Abstract][Full Text] [Related]
7. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Sommat K; Ong WS; Hussain A; Soong YL; Tan T; Wee J; Fong KW
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):574-580. PubMed ID: 28581397
[TBL] [Abstract][Full Text] [Related]
8. Early post-treatment
Lu HH; Chiu NT; Tsai MH
Cancer Imaging; 2022 Oct; 22(1):59. PubMed ID: 36217182
[TBL] [Abstract][Full Text] [Related]
9. A dosimetric study on radiation-induced hypothyroidism following intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma.
Xu Y; Shao Z; Tang T; Liu G; Yao Y; Wang J; Zhang L
Oncol Lett; 2018 Nov; 16(5):6126-6132. PubMed ID: 30405757
[TBL] [Abstract][Full Text] [Related]
10. Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose-volume constraints with long-term endocrine outcomes.
Chow JCH; Lui JCF; Cheung KM; Tam AHP; Lam MHC; Yuen TYS; Lee FKH; Leung AKC; Au KH; Ng WT; Lee AWM; Kwan CK; Yiu HHY
Radiother Oncol; 2022 Dec; 177():105-110. PubMed ID: 36336109
[TBL] [Abstract][Full Text] [Related]
11. External validation of a normal tissue complication probability model for radiation-induced hypothyroidism in an independent cohort.
Rønjom MF; Brink C; Bentzen SM; Hegedüs L; Overgaard J; Petersen JB; Primdahl H; Johansen J
Acta Oncol; 2015; 54(9):1301-9. PubMed ID: 26248025
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced hypothyroidism in patients with breast cancer: a retrospective analysis of 243 cases.
Kanyilmaz G; Aktan M; Koc M; Demir H; Demir LS
Med Dosim; 2017 Autumn; 42(3):190-196. PubMed ID: 28502654
[TBL] [Abstract][Full Text] [Related]
13. The threshold of hypothyroidism after radiation therapy for head and neck cancer: a retrospective analysis of 116 cases.
Fujiwara M; Kamikonya N; Odawara S; Suzuki H; Niwa Y; Takada Y; Doi H; Terada T; Uwa N; Sagawa K; Hirota S
J Radiat Res; 2015 May; 56(3):577-82. PubMed ID: 25818629
[TBL] [Abstract][Full Text] [Related]
14. Is thyroid gland an organ at risk in breast cancer patients treated with locoregional radiotherapy? Results of a pilot study.
Tunio MA; Al Asiri M; Bayoumi Y; Stanciu LG; Al Johani N; Al Saeed EF
J Cancer Res Ther; 2015; 11(4):684-9. PubMed ID: 26881502
[TBL] [Abstract][Full Text] [Related]
15. Factors predictive of the development of hypothyroidism after intensity-modulated radiation therapy for pharyngeal cancer.
Inoue E; Okajima K; Doi H; Fukuda K; Oguma Y; Ri A; Nishikawa D; Yane K; Matsuura T; Nishimura Y
Acta Otolaryngol; 2021 Nov; 141(11):1022-1026. PubMed ID: 34738883
[TBL] [Abstract][Full Text] [Related]
16. Thyroid V40 is a good predictor for subclinical hypothyroidism in patients with nasopharyngeal carcinoma after intensity modulated radiation therapy: a randomized clinical trial.
Xu Y; Peng H; Su G; Cheng Y; Guo Q; Guo L; Peng XE; Ke J
Radiat Oncol; 2023 Aug; 18(1):141. PubMed ID: 37626342
[TBL] [Abstract][Full Text] [Related]
17. Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer.
Kim MY; Yu T; Wu HG
Jpn J Clin Oncol; 2014 Apr; 44(4):331-7. PubMed ID: 24482412
[TBL] [Abstract][Full Text] [Related]
18. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials.
Murthy V; Narang K; Ghosh-Laskar S; Gupta T; Budrukkar A; Agrawal JP
Head Neck; 2014 Nov; 36(11):1573-80. PubMed ID: 23996654
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy.
Chyan A; Chen J; Shugard E; Lambert L; Quivey JM; Yom SS
Radiat Oncol; 2014 Dec; 9():269. PubMed ID: 25476839
[TBL] [Abstract][Full Text] [Related]
20. Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT).
Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2017 Aug; 40(4):413-417. PubMed ID: 25503434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
